Keyphrases
Primary Hyperparathyroidism (pHPT)
100%
Therapeutic Challenges
50%
Characteristic Risk
50%
Ethnic Background
50%
Elderly Patients
50%
Clinical Characteristics
50%
Cardiovascular Risk
50%
African American
25%
African American Patients
25%
Intact Parathyroid Hormone (iPTH)
18%
Adenoma
18%
Urine Calcium
12%
Parathyroid Hormone Levels
12%
Renal Stone
12%
Body Mass Index
12%
Serum Calcium
12%
24-hour Urine Collection
12%
Medically Managed
9%
Osteoblastic Lesions
8%
Type I Collagen Fibrils
8%
Low Dose Rate
6%
Laboratory Values
6%
Hispanic
6%
25-hydroxyvitamin D (25OHD)
6%
Parathyroid Adenoma
6%
High Prevalence
6%
Type 1 Diabetes Mellitus (T1DM)
6%
Hypertension
6%
Ethnic Groups
6%
University Hospital
6%
25(OH) Vitamin D
6%
Medicine and Dentistry
Primary Hyperparathyroidism
100%
Elderly Patient
50%
Bone Metastasis
50%
Acid Phosphatase Prostate Isoenzyme
50%
Cardiovascular Risk
50%
Prostate Cancer
50%
Isotopes of Calcium
25%
Parathyroid Hormone
18%
Adenoma
18%
Body Mass Index
18%
Hormone Determination
12%
Kidney Stone
12%
Nuclear Factor
11%
Receptor
11%
Diabetes Mellitus
6%
Parathyroid Adenoma
6%
Prevalence
6%
Retrospective Study
6%
Vitamin D
6%
Ethnic Group
6%
Hyperlipidemia
6%
Bone Marrow Suppression
5%
Cancer Cell
5%
Bone Mineralization
5%
Hormone Therapy
5%
Adenosine
5%
Tumor Marker
5%
Radiation Therapy
5%
Collagen Type 1
5%
Signal Transduction
5%
Spinal Cord Compression
5%
Secretory Protein
5%
Osteoclast Differentiation Factor
5%
Phosphatase
5%
Homeostasis
5%
Collagen Fibril
5%
Chemotherapy
5%
Solid Malignant Neoplasm
5%
Prostate Epithelium
5%
Nucleotidase
5%
Pharmacology, Toxicology and Pharmaceutical Science
Primary Hyperparathyroidism
100%
Cardiovascular Risk
50%
Parathyroid Hormone
18%
Adenoma
18%
Nephrolithiasis
12%
Retrospective Study
6%
Vitamin D
6%
Hyperlipidemia
6%
Parathyroid Adenoma
6%
Prevalence
6%
Diabetes Mellitus
6%